Meeting Overview - The annual general meeting of shareholders was held on May 21, 2025, at the company's headquarters in Kunming, Yunnan Province [2] - The meeting was convened by the board of directors and chaired by the chairman, Mr. Lan Bo, in compliance with the Company Law and the company's articles of association [2] Attendance and Voting - All 7 current directors and 3 supervisors attended the meeting, along with the board secretary and the general manager [3] - There were no rejected resolutions during the meeting [2] Resolutions Passed - The following resolutions were approved: - 2024 Annual Board Work Report [3] - 2024 Annual Supervisory Work Report [3] - 2024 Annual Independent Director Work Report [4] - 2024 Financial Settlement Report [4] - 2025 Financial Budget Plan [4] - 2024 Profit Distribution Plan [4] - Approval of the 2024 Annual Report and its summary [4] - Reappointment of the auditing firm for 2025 [4] - Approval for the company and its subsidiaries to apply for comprehensive credit lines and provide guarantees [4] - Approval of the estimated related party transactions for 2025 [5] Legal Verification - The meeting was witnessed by Beijing Deheng (Kunming) Law Firm, confirming that the meeting's convening, attendance, and voting procedures complied with legal and regulatory requirements [5]
健之佳医药连锁集团股份有限公司2024年年度股东会决议公告